Injective (INJ) has entered a precarious phase after its recent upward momentum hit a wall at a major psychological and technical resistance zone. While the broader market sentiment remains cautiously optimistic, INJ is struggling to sustain its breakout, leading to a tug-of-war between bulls and bears. This stall comes at a time when the overall altcoin market is seeking direction following recent volatility in major assets like Bitcoin.
From a technical perspective, the contradiction stems from strong fundamental growth within the Injective ecosystem versus cooling RSI (Relative Strength Index) levels on the daily chart. While institutional interest in Injective's high-speed DeFi infrastructure remains robust, short-term profit-taking is exerting downward pressure on the price. Traders are currently caught between the fear of a fake-out and the FOMO of a potential secondary leg up.
Investors should keep a close eye on the current support floors; a decisive break below local liquidity zones could signal a deeper correction toward previous consolidation ranges. Conversely, a confirmed close above the recent roadblock could reignite the rally toward new yearly highs. As US markets continue to react to shifting macro liquidity, INJ's ability to hold its ground will be a litmus test for broader high-beta altcoin resilience.